Metformina Ratiopharm

Metformin Hydrochloride, the active ingredient in Metformina Ratiopharm, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑sugar control.

GNH USA supplies Metformina Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Ratiopharm is a biguanide indicated for disorders of glucose metabolism. - Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. - Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity.

Metformina Ratiopharm may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: usually when combined with insulin or sulfonylureas. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: rare liver enzyme elevations. - Skin rash or hypersensitivity: including Stevens‑Johnson syndrome. - Pancreatitis: very uncommon inflammation of the pancreas.

Metformina Ratiopharm requires careful monitoring and patient education. - Renal function assessment: avoid use if eGFR <30 mL/min/1.73 m². - Hepatic function monitoring: use with caution in liver disease. - Blood glucose monitoring: adjust dose based on glycaemic response. - Elderly patients: start at lower dose and titrate slowly. - Concomitant alcohol use: limit intake to reduce lactic acidosis risk. - Store at room temperature: keep in the original pack, protect from moisture.

Metformina Ratiopharm can interact with several medicines, altering its safety or efficacy.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis. - Cimetidine: increases metformin plasma concentrations. - Trimethoprim: reduces renal clearance of metformin. - Excessive alcohol: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: monitor renal function and potassium. - Diuretics: assess for dehydration and renal impairment. - Corticosteroids: may raise blood glucose, requiring dose adjustment. - Thyroid hormones: monitor for altered glucose metabolism.